Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+Mozilla Firefox 20+Internet Explorer 11Opera 15–18Apple Safari 7SeaMonkey 2.15-2.23

Poster display session: Breast cancer - early stage, locally advanced & metastatic, CNS tumours, Developmental therapeutics, Genitourinary tumours - prostate & non-prostate, Palliative care, Psycho-oncology, Public health policy, Sarcoma, Supportive care

3654 - Sexual function and quality of life in a national cohort of bilateral testicular cancer survivors

Date

22 Oct 2018

Session

Poster display session: Breast cancer - early stage, locally advanced & metastatic, CNS tumours, Developmental therapeutics, Genitourinary tumours - prostate & non-prostate, Palliative care, Psycho-oncology, Public health policy, Sarcoma, Supportive care

Topics

Tumour Site

Malignant Germ-Cell Tumours of the Adult Male

Presenters

Mikkel Bandak

Citation

Annals of Oncology (2018) 29 (suppl_8): viii303-viii331. 10.1093/annonc/mdy283

Authors

M. Bandak1, J. Lauritsen1, C. Johansen1, M.B. Kreiberg1, J.W. Skøtt1, M. Agerbaek2, N.W. Holm3, K.G. Daugaard1

Author affiliations

  • 1 Department Of Oncology, Copenhagen University Hospital - Rigshospitalet, 2100 - Copenhagen/DK
  • 2 Department Of Oncology, Aarhus University hospital, Aarhus/DK
  • 3 Department Of Oncology, Odense University Hospital, 5000 - Odense/DK
More

Abstract 3654

Background

Sexual function and quality of life remain unexplored in long-term survivors of bilateral testicular cancer (TC). The aim was to investigate sexual function, fatigue, anxiety and depression in long-term survivors of bilateral TC (unilateral TC with contralateral germ cell neoplasia in situ (TC+GCNIS) or bilateral TC (BTC)).

Methods

Cross-sectional study of 2479 long-term TC survivors of whom 126 were treated with contralateral radiotherapy due to GCNIS, 93 were treated with bilateral orchiectomy due to BTC and 2260 had unilateral TC (reference group). Outcomes were assessed with validated questionnaires with a median time since diagnosis of 17 years (interquartile range (IQR) 12-23 years). Results in TC+ GCNIS and BTC were compared with the reference group. Adjustment was made for age and treatment for disseminated disease.

Results

The age-adjusted risk of anxiety was significantly increased in BTC survivors (odds ratio 1.7 (1.1-2.8) p = 0.002). Apart from increased risk of reduced motivation in survivors with TC+GCNIS there were no other significant differences between the groups. Limitations include the few cases with symptoms of depression.

Conclusions

Survivors of BTC had increased risk of anxiety but did not experience impairment of other aspects of quality of life. These results are of importance for evidence-based information on late effects for bilateral TC patients.

Clinical trial identification

Legal entity responsible for the study

Danish Testicular Cancer Group (Dateca).

Funding

Copenhagen University Hospital Rigshospitalet.

Editorial Acknowledgement

Disclosure

All authors have declared no conflicts of interest.

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings
  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.